Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia

Published:2011-12-06 Issue:6 Volume:53 Page:1023-1031
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Seiffert Martina¹,Dietrich Sascha²,Jethwa Alexander³,Glimm Hanno³,Lichter Peter¹,Zenz Thorsten²³

Affiliation:

1. Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany

2. Department of Medicine V, University of Heidelberg, Heidelberg, Germany

3. Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.631638

Reference99 articles.

1. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells

2. Chronic Lymphocytic Leukemia

3. Novel Insights in Chronic Lymphocytic Leukemia: Are We Getting Closer to Understanding the Pathogenesis of the Disease?

4. From pathogenesis to treatment of chronic lymphocytic leukaemia

5. Biological diversity and risk-adapted treatment of chronic lymphocytic leukemia

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilizing risk factors to guide treatment decisions in chronic lymphocytic leukemia;Expert Review of Anticancer Therapy;2024-09-02

2. Circular RNA as a Biomarker for Diagnosis, Prognosis and Therapeutic Target in Acute and Chronic Lymphoid Leukemia;Cell Biochemistry and Biophysics;2024-08-13

3. GLP and G9a histone methyltransferases as potential therapeutic targets for lymphoid neoplasms;Cancer Cell International;2024-07-12

4. An overview of prognostic markers in patients with CLL;Frontiers in Oncology;2024-05-16

5. Potential New Therapies “ROS-Based” in CLL: An Innovative Paradigm in the Induction of Tumor Cell Apoptosis;Antioxidants;2024-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3